Isolated limb perfusion for melanoma

Journal of Surgical Oncology

Volumn 79, Issue 4, 2002, Pages 252-255

  Kroon, Bin B R ^a   Noorda, Eva M ^a   Vrouenraets, Bart C ^b   Nieweg, Omgo E ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

DRUG MEGADOSE; HUMAN; INOPERABLE CANCER; LIMB PERFUSION; MELANOMA; PRIORITY JOURNAL; RECURRENT CANCER; REVIEW;

ANTINEOPLASTIC AGENTS, ALKYLATING; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COMBINED MODALITY THERAPY; HUMANS; LEG; MELANOMA; MELPHALAN; NEOPLASM RECURRENCE, LOCAL; SKIN NEOPLASMS;

EID: 0036207232     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10077     Document Type: Review

References (16)

1. Regional isolation perfusion in melanoma of the limbs: Accomplishments, unsolved problems, future
2. Results of regional isolated perfusion in locally inoperable melanoma of the limbs
3. Thirty-five years of isolated limb perfusion for melanoma: Indications and results
4. Repeat isolated limb perfusion with Melphalan for recurrent melanoma of the limbs
5. A retrospective comparative study evaluating the results of a single-perfusion versus double-perfusion schedule with Melphalan in patients with recurrent melanoma of the lower limb
6. A retrospective comparative study evaluating the results of mild hyperthermic versus controlled normothermic perfusion for recurrent melanoma of the extremities
7. Results of a double perfusion schedule using high-dose hyperthermia and Melphalan sequentially for recurrent melanoma of the limbs: A pilot study
8. High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma
9. Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit metastases: A multicentre randomized phase II study
10. Systemic leakage during isolated limb perfusion for melanoma
11. Absence of severe systemic toxicity after leakage controlled isolated limb perfusion with tumor necrosis factor-α and melphalan
12. Isolated limb infusion with cytotoxic agents: A simple alternative to isolated limb perfusion
13. Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities
14. Chemotherapy of cancer: Regional perfusion utilizing an extracorporeal circuit
15. Prophylactic isolated limb perfusion for localized, high-risk limb melanoma: Results of a multicenter randomized phase III trial
16. Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: Review of a large single-institutional experience with an emphasis on recurrence